These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Naturally occurring immunomodulators with antitumor activity: An insight on their mechanisms of action. Mohamed SIA; Jantan I; Haque MA Int Immunopharmacol; 2017 Sep; 50():291-304. PubMed ID: 28734166 [TBL] [Abstract][Full Text] [Related]
7. The therapeutic potential of microbial proteasome inhibitors. Momose I; Kawada M Int Immunopharmacol; 2016 Aug; 37():23-30. PubMed ID: 26589840 [TBL] [Abstract][Full Text] [Related]
8. Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers. Buchwald UK; Pirofski L Curr Pharm Des; 2003; 9(12):945-68. PubMed ID: 12678861 [TBL] [Abstract][Full Text] [Related]
9. Modulation of Toll-like receptor signaling in innate immunity by natural products. Chen L; Yu J Int Immunopharmacol; 2016 Aug; 37():65-70. PubMed ID: 26899347 [TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
11. Interaction of natural products with cell survival and signaling pathways in the biochemical elucidation of drug targets in cancer. Qurishi Y; Hamid A; Majeed R; Hussain A; Qazi AK; Ahmed M; Zargar MA; Singh SK; Saxena AK Future Oncol; 2011 Aug; 7(8):1007-21. PubMed ID: 21823895 [TBL] [Abstract][Full Text] [Related]
12. Oceans as a Source of Immunotherapy. Ahmad B; Shah M; Choi S Mar Drugs; 2019 May; 17(5):. PubMed ID: 31083446 [TBL] [Abstract][Full Text] [Related]
13. A mouse model-based screening platform for the identification of immune activating compounds such as natural products for novel cancer immunotherapies. Richter L; Kropp S; Proksch P; Scheu S Bioorg Med Chem; 2019 Dec; 27(23):115145. PubMed ID: 31648874 [TBL] [Abstract][Full Text] [Related]
14. Natural products in drug discovery: advances and opportunities. Atanasov AG; Zotchev SB; Dirsch VM; ; Supuran CT Nat Rev Drug Discov; 2021 Mar; 20(3):200-216. PubMed ID: 33510482 [TBL] [Abstract][Full Text] [Related]
16. Biological response modifiers: current use and future prospects in cancer therapy. Bisht M; Bist SS; Dhasmana DC Indian J Cancer; 2010; 47(4):443-51. PubMed ID: 21131760 [TBL] [Abstract][Full Text] [Related]
17. Editorial overview: Immunomodulation: Striking the right balance: using immunomodulators to target infectious diseases, cancer, and autoimmunity. Lavelle EC; McLachlan JB Curr Opin Pharmacol; 2018 Aug; 41():vii-ix. PubMed ID: 30139514 [No Abstract] [Full Text] [Related]
18. Biological agents in treatment of cancer. Hersey P Aust N Z J Med; 1990 Feb; 20(1):85-98. PubMed ID: 2181990 [No Abstract] [Full Text] [Related]
19. Immunomodulatory approaches for prevention and treatment of infectious diseases. Nijnik A Curr Opin Microbiol; 2013 Oct; 16(5):590-5. PubMed ID: 23870826 [TBL] [Abstract][Full Text] [Related]
20. Biologics for the treatment of autoimmune renal diseases. Holdsworth SR; Gan PY; Kitching AR Nat Rev Nephrol; 2016 Apr; 12(4):217-31. PubMed ID: 26949177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]